跳至主要内容
临床试验/NCT05283876
NCT05283876已完成不适用

Excimer Light Effect on Neurogenic Inflammation in Developing Versus Stationary Psoriasis Lesions

Cairo University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年3月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Excimer laser efficiency in active and stable psoriasis

研究概览

简要总结

The aim of this study is to determine the standard tissue levels of SP and its receptor in lesional skin of psoriasis patients in both developing and stationary stages before and after excimer light therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type of Psoriasis: plaque psoriasis.
  • Less than 10% surface area.

排除标准

  • Erythrodermic psoriasis
  • Pustular psoriasis
  • Topical treatment for psoriasis for the past 2 weeks.
  • Systemic retinoids in the last 2 years.
  • Systemic treatments (including any drugs that affect SP level as Aprepitant) in the last 3 months.
  • Contraindications to excimer light therapy (history of skin malignancy or precancerous conditions like xeroderma pigmentosum or photosensitivity)

结局指标

主要结局

Excimer laser efficiency in active and stable psoriasis

时间窗: through study completion, an average of 6 months

Determine the clinical improvement using Local psoriasis severity index

Excimer laser efficiency on neurogenic inflammation

时间窗: through study completion, an average of 6 months

level of affection of the neurogenic inflammation in psoriasis lesions after using Excimer light therapy. Determine substance P and its receptor levels before and after therapy.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marwa Salah El-Din El-Mesidy

Dr.

Cairo University

研究点 (1)

Loading locations...

相似试验

Excimer Light in Psoriasis | 临床试验